SCHEMBL565020

SCHEMBL565020

COc1ccc(CN2CC[C@@H](C(=O)N(Cc3cc(Cl)c4c(c3)OCCCO4)CC(C)C)C2)cc1N

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.66
KDM4E B2RXH2 4/20 0.43
LMNA P02545 1/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 1/20 0.40
PDCD1 Q15116 3/20 0.37
CD274 Q9NZQ7 3/20 0.37
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
CHRM2 P08172 1/20 0.37
ADRA2A P08913 1/20 0.37
CHRM1 P11229 1/20 0.37
DRD2 P14416 1/20 0.37
ADRA2B P18089 1/20 0.37
CHRM3 P20309 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10119856 1.00 PROKR2 (0.66) PROKR2KDM4ELMNAKMT2AMEN1
SCHEMBL10106753 0.91 PROKR2 (0.65) PROKR2KDM4EKMT2AMEN1ALDH1A1
SCHEMBL10107548 0.90 PROKR2 (0.81) PROKR2KDM4ELMNAKMT2AMEN1
SCHEMBL10107211 0.90 PROKR2 (0.66) PROKR2KDM4EKMT2AMEN1ALDH1A1
SCHEMBL564621 0.90 PROKR2 (0.81) PROKR2KDM4ELMNAKMT2AMEN1
SCHEMBL564976 0.90 PROKR2 (0.66) PROKR2KDM4EKMT2AMEN1ALDH1A1
SCHEMBL564982 0.90 PROKR2 (0.66) PROKR2KDM4EKMT2AMEN1ALDH1A1
SCHEMBL564990 0.90 PROKR2 (0.67) PROKR2KDM4EKMT2AMEN1
SCHEMBL564942 0.90 PROKR2 (0.69) PROKR2KDM4EKMT2AMEN1ALDH1A1
SCHEMBL10119857 0.90 PROKR2 (0.64) PROKR2KDM4ELMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885KDM4E 4874/4885LMNA 704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.